According to a new study, a high level of caffeine in the blood could curb body fat and the risk of type 2 diabetes. However, this effect may only be apparent in individuals with a certain genetic predisposition.
Previous studies had already established a link between coffee consumption and a reduced risk of diabetes. But this research remained observational. A new study, conducted by researchers from the Karolinska Institute, the University of Bristol and Imperial College London, used another approach to test this hypothesis: genetics.
For the purposes of their study, the researchers used the Mendelian randomization technique, which establishes causation through genetic evidence. The researchers identified two common genetic mutations that affect the rate of caffeine metabolism in the body, CYP1A2 and AHR. As a result, blood caffeine levels could be sequenced and analyzed to see if they were associated with a lower BMI and a lower risk of diabetes.
From a sample of around 10,000 people, the researchers noticed that people with variations in these two genes metabolize caffeine more slowly. They don't need to drink a lot of caffeinated beverages to benefit from the stimulant's effects, because its absorption is more effective. These people have higher levels of caffeine in their blood than people who metabolize caffeine more quickly.
The results also showed that people with high levels of caffeine in their blood have a lower BMI and body fat than others. They also have a lower risk of type 2 diabetes.
"Our mendelian randomization finding suggests that caffeine might, at least in part, explain the inverse association between coffee consumption and risk of type 2 diabetes," said Dr Susanna Larsson, associate professor in the Institute of Environmental Medicine at the Karolinska Institute, and lead author of the paper, quoted in a news release.
However, the researchers acknowledge various limitations to their findings, including the use of only two genetic variants and the inclusion of individuals primarily of European descent.
Still, the study may offer promising new solutions to treatment of obesity and type 2 diabetes. Benjamin Woolf, PhD student in the Tobacco and Alcohol Research Group at the University of Bristol, co-author who led on the statistics for the paper, added: "Randomized controlled trials are warranted to assess whether non-caloric caffeine containing beverages might play a role in reducing the risk of obesity and type 2 diabetes."
Reference Provided by ETX
※ Picks respects the rights of all copyright holders. If you do wish to make material edits, you will need to run them by the copyright holder for approval.
more from
ETX
ETX
There's a generation of employees who have never known the world of regular office hours
2025-04-22 00:00:00
ETX
Europe's most feline-dense country is...
2025-04-22 00:00:00
ETX
Swap coffee for natural light for a better morning wakeup
2025-04-21 00:00:00
ETX
Birds' songs are the reflection of their personality
2025-04-21 00:00:00
BEST STORIES
ETX
Greener weddings: ways to choose more eco-friendly wedding dress
2025-04-19 00:00:00
The Conversation
'Peru's ancient irrigation systems succeeded in turning deserts into farms because of the culture - without it, the systems failed'
2025-04-16 00:00:00
KoreaJoongAngDaily
Of love, peace and BTS: Coldplay 'sings magic for every heart' in Korea
2025-04-20 00:00:00
Inven Global
Hanwha Life Esports Emerges as Championship Favorite at LCK Media Day
2025-04-16 00:00:00
Health
ETX
Is generosity a question of heart or the amygdala?
2025-04-20 00:00:00
ETX
How your figure could bear a lasting imprint of the weather from decades ago
2025-04-12 00:00:00
ETX
The scientist rewriting DNA, and the future of medicine